Stock Screener App

Frei -

Installieren

22.84

1.02% 0.23

Vorhandelsmarkt: 22.84

Ultragenyx Pharmaceutical Inc (RARE)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt RARE? Forum Prognose Aktiensplit

Ultragenyx Pharmaceutical Inc Aktie (RARE) Neueste Nachrichten

Insider Sell: Karah Parschauer Sells Shares of Ultragenyx Pharma - GuruFocus

RARE Investors Have Opportunity to Lead Ultragenyx - GlobeNewswire

Investors who lost money on Ultragenyx Pharmaceutical Inc.(RARE) should contact The Gross Law Firm about pending Class ActionRARE - Morningstar

Ultragenyx EVP Pinion sells $228k in shares - Investing.com Nigeria

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Biopharma Brass Hid Drug Trial Risks, Derivative Suit Says - Law360

RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit - Financial Times

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ultragenyx - GlobeNewswire

Levi & Korsinsky, LLP: Institutional Investor Notice --- Ultragenyx Pharmaceutical Lead Plaintiff Opportunity - GlobeNewswire

Ultragenyx Pharmaceutical (NASDAQ:RARE) Shares Up 5.6%Still a Buy? - MarketBeat

Portnoy Law Firm Announces Class Action on Behalf of Ultragenyx Pharmaceutical, Inc. Investors - GlobeNewswire

FinancialContentUltragenyx Pharmaceutical Inc. (RARE) Class Action Lawsuit Seeks Recovery for Investors; April 6, 2026, DeadlineContact Kessler Topaz Meltzer & Check, LLP - FinancialContent

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Richtech Robotics Inc. (RR), Ultragenyx Pharmaceutical Inc. (RARE), and Mereo BioPharma Group plc (MREO) Announced by Holzer & Holzer, LLC - marketscreener.com

CLASS ACTION INVESTOR ALERTS: Bragar Eagel & Squire, P.C. - GlobeNewswire

RARE Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages RARE Investors with Losses to Contact the Firm - Financial Times

Ultragenyx Pharmaceutical Inc. (RARE) Investors: April 6, 2026, Filing Deadline in Securities Fraud Class Action - GlobeNewswire Inc.

Analysis Recap: Can Ultragenyx Pharmaceutical Inc. (UP0) stock stage a strong rebound this quarter2025 Trade Ideas & Community Verified Trade Alerts - Naître et grandir

Ultragenyx Pharmaceutical Inc. $RARE Stock Position Increased by Blue Owl Capital Holdings LP - MarketBeat

Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc.RARE - StreetInsider

ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Contact The Gross Law Firm by April 6, 2026 Deadline to Join Class Action Against Ultragenyx ... - Bluefield Daily Telegraph

RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire

Ultragenyx Pharmaceutical Inc. (RARE) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - FinancialContent

RARE CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ultragenyx Investors of Securities Class Action Deadline on April 6, 2026 – Company Announcement - Financial Times

GW&K Investment Management LLC Buys 668,881 Shares of Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action LawsuitRGRD Law - Sahm

Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - ACCESS Newswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ultragenyx Pharmaceutical Inc. of Class Action Lawsuit and Upcoming DeadlinesRARE - PR Newswire

Skeletal Dysplasia Market - GlobeNewswire Inc.

Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors - GlobeNewswire

Ultragenyx Pharmaceutical Inc. (RARE) Class Action Lawsuit: Investors Face April 6, 2026, Deadline - NewMediaWire

Robbins LLP Urges RARE Stockholders to Contact the Firm for - GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

UPCOMING DEADLINE: Ultragenyx Pharmaceutical Inc. (RARE) Securities Fraud Class Action – April ... - Bluefield Daily Telegraph

UPCOMING DEADLINE: Ultragenyx Pharmaceutical Inc. (RARE) - GlobeNewswire

Ultragenyx Pharmaceutical Inc. $RARE Shares Bought by Rafferty Asset Management LLC - MarketBeat

Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 - GlobeNewswire

Navan, Inc. Notice of April 24, 2026 Application Deadline for Class Action Lawsuit - GlobeNewswire Inc.

Ultragenyx Pharmaceutical (NASDAQ:RARE) Insider Sells $228,661.20 in Stock - MarketBeat

Howard Horn Sells 1,635 Shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock - MarketBeat

Ultragenyx Pharmaceutical (NASDAQ:RARE) EVP Sells $185,478.00 in Stock - MarketBeat

Theodore Alan Huizenga Sells 1,632 Shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock - MarketBeat

Ultragenyx Pharmaceutical (NASDAQ:RARE) EVP Eric Crombez Sells 7,029 Shares - MarketBeat

Ultragenyx Pharmaceutical (NASDAQ:RARE) EVP Sells 10,539 Shares - MarketBeat

Ultragenyx Pharmaceutical (NASDAQ:RARE) CFO Sells $190,884.30 in Stock - MarketBeat

Ultragenyx Pharmaceutical (NASDAQ:RARE) CEO Sells 54,404 Shares - MarketBeat

Ultragenyx (RARE) CEO logs share award and tax-driven stock sale - Stock Titan

Ultragenyx (RARE) legal chief receives stock award, sells shares for taxes - Stock Titan

Ultragenyx (RARE) CAO disposes shares in RSU tax-related transactions - Stock Titan

Ultragenyx (RARE) CFO nets stock award and sells 10,044 shares - Stock Titan

Ultragenyx (RARE) CMO reports stock award and sale of common shares - Stock Titan

Ultragenyx (RARE) executive reports stock grant and tax share surrender - Stock Titan

User - The Chronicle-Journal

Shareholders that lost money on Ultragenyx Pharmaceutical Inc.(RARE) Urged to Join Class ActionContact The Gross Law Firm to Learn More - StreetInsider

Experts: Regulatory roadblocks stalling rare disease therapies - bioworld.com

Shareholders that lost money on Ultragenyx Pharmaceutical Inc.(R - GuruFocus

Howard Horn sells RARE shares (NASDAQ: RARE) in Form 144 disclosure - Stock Titan

Levi & Korsinsky, LLP: Section 10(b) and Rule 10b-5 Claims Filed Against Ultragenyx ... - Bluefield Daily Telegraph

Levi & Korsinsky, LLP: Section 10(b) and Rule 10b-5 Claims Filed Against Ultragenyx Pharmaceutical - marketscreener.com

NASDAQ: RARE Berger Montague Advises Ultragenyx Pharmaceutical Inc. (NASDAQ - marketscreener.com

Ultragenyx Pharmaceutical Inc. (RARE) Class Action Lawsuit Seeks Recovery for Investors; April 6, 2026, DeadlineContact Kessler Topaz Meltzer & Check, LLP – Company AnnouncementFT.com - Financial Times

Ultragenyx Pharmaceutical Inc. Investors with Substantial - GlobeNewswire

Ultragenyx Pharmaceutical Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsRARE - marketscreener.com

RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm – Company AnnouncementFT.com - Financial Times

RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

RPRX

$45.97

0.28%

BNTX

$83.89

17.88%

ROIV

$29.70

0.58%

MRNA

$54.98

1.36%

INSM

$143.85

0.50%

ONC

$305.39

1.03%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters